Univenture, Inc.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes and other financial information included elsewhere in this offering. Some of the information contained in this discussion and analysis, including information regarding the strategy and plans for our business, includes forward-looking statements that involve risks and uncertainties. You should review the "Risk Factors" section for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

Overview

Award winning tech platform with high ROI for mail & packaging!

As a diversified company we have a number of successful technologies that have led to hundreds of successful products. Our big idea is the continued support for Biosortia, EnvyPak, UniKeep and CARDNOTER brands and platforms. These efforts could lead to substantial growth and the opportunity to drive sustainable profits for decades.

Univenture, Inc. makes products customers want from a variety of platforms that must be at least one of the following; Better, Faster, Cheaper, or Differentiated.
Univenture, Inc. is a diversified and profitable company with massive potential because of technologies.

Univenture, Inc. strives to continue to be creative and innovative. We will build on experience and success to bring new products and technologies into the market to drive revenue and profit expansion. Our goal is to become a publicly traded company and expand via access to capital, technology, and the excellence of our high performing team dynamic.
These projections cannot be guaranteed.

Milestones

Univenture, Inc. was incorporated in the State of Delaware in June 1988.

Since then, we have:

• 💰 Profitable, growing, unique consumer organization & business presentation products, 75 patents issued worldwide
• 📈 Over $430 Million in total sales, and 27 profitable years with a non-concentrated customer base
• 🎬 Multiple brands growing with substantial Upside Potential, including a growing interest in a disruptive Biotech
• 🏆 5 time INC 500 awardee, Nations SBA Business Person of the Year, and dozens of other awards and honors for TEAM
• 💪 Fortune 500, business customers and consumers love our products
• 👩‍🔬 The partially owned biotech received funding from ARPA-E, DARPA, USAF-RL near $9 million and $12 million dilutive
• 🌎 ESG - An inclusive, socially responsible, environmentally focused company

Historical Results of Operations

• Revenues & Gross Margin. For the period ended March 31, 2023, the Company had revenues of $7,602,944 compared to the year ended March 31, 2022, when the Company had revenues of $6,634,177. Our gross margin was 31.06% in fiscal year 2023, compared to 37.48% in 2022.
• Assets. As of March 31, 2023, the Company had total assets of $5,364,952, including $1,350,711 in cash. As of March 31, 2022, the Company had $4,738,980 in total assets, including $961,234 in cash.
• Net Loss. The Company has had net losses of $47,882 and net income of $358,010 for the fiscal years ended March 31, 2023 and March 31, 2022, respectively.
• Liabilities. The Company's liabilities totaled $3,561,717 for the fiscal year ended March 31, 2023 and $2,887,863 for the fiscal year ended March 31, 2022.

Related Party Transaction

Refer to Question 26 of this Form C for disclosure of all related party transactions.

Liquidity & Capital Resources

To-date, the company has been financed with $5,774,522 in debt and $164,200 in equity.

After the conclusion of this Offering, should we hit our minimum funding target, our projected runway is 12 months before we need to raise further capital.

We plan to use the proceeds as set forth in this Form C under "Use of Funds". We don’t have any other sources of capital in the immediate future.

We will likely require additional financing in excess of the proceeds from the Offering in order to perform operations over the lifetime of the Company. Except as otherwise described in this Form C, we do not have additional sources of capital other than the proceeds from the offering. Because of the complexities and uncertainties in establishing a new business strategy, it is not possible to adequately project whether the proceeds of this offering will be sufficient to enable us to implement our strategy. This complexity and uncertainty will be increased if less than the maximum amount of securities offered in this offering is sold. The Company intends to raise additional capital in the future from investors. Although capital may be available for early-stage companies, there is no guarantee that the Company will receive any investments from investors.

Runway & Short/Mid Term Expenses

Univenture, Inc. cash in hand is $321,050.63, as of March 2024. Over the last three months, revenues have averaged $291,757/month, cost of goods sold has averaged $257,541/month, and operational expenses have averaged $179,706/month, for an average burn rate of $145,490 per month. Our intent is to be profitable in 1 months.Since the date of our financials, we have received Employee Retention Tax Credit (ERC) for CY 21 Q2 at $239,523 and Q3 at $255,790.   We received loan from Paycheck Protection Program (PPP) of $340,229 that was forgiven in June 2021.
Due to the pandemic we expect year over year to be up in the 10-15% in the next 3-6 months.  We expect to be able to deploy the investment from our funding round into the growth objectives covered in the use of funds.  Depending on unanticipated financial impacts from the Russian War on Ukraine.  We expect breakeven or better during this time frame. Specifically, we hope to be generating approximately $750,000/month in revenues and incurring $720,000/month in expenses by October 2022.
We are profitable and expect to be profitable in the future.  We expect to be able to deploy the investment from our funding round into the growth objectives covered in the use of funds.
For additional capital outside of this offering, Univenture, Inc. is expected to utilize profits for growth.  Cash flow is positive and we are paying down debt.  Additional assets will be purchased to increase capacity and capabilities.
All projections in the above narrative are forward-looking and not guaranteed.